Home|Journals|Articles by Year|Audio Abstracts

Original Article

J App Pharm Sci. 2023; 13(2): 154-160

Phytochemical screening, proximate composition, and antihyperlipidemic activity of the barley-rich nutraceutical combination in triton X-100-induced hyperlipidemic Wistar rats

Samreen M. Sheik, Karkala Sreedhara Ranganath Pai, B. S. Mamatha, H. Madhukar Mallya, Vani Lakshmi Ramesh Iyer, Varashree Bolar Suryakanth, Deepak Nayak Manel, Pallavi Mahesh Shettigar, Revathi P. Shenoy.

Cited by 1 Articles

Cardiovascular disorders are associated with hyperlipidemia, and statin therapy is the first line of treatment, with several side effects. To prevent hyperlipidemia and for cost-effectiveness with no side effects, the study aimed to develop a nutraceutical recipe. For 15 days, the Wistar rats were fed an oral diet supplemented with barley, foxtail millet, flaxseeds, moong, and fish oil. Each rat was treated with Triton X-100 intraperitoneally to induce hyperlipidemia. The serum lipid profiles were measured. Diet formulations rich in flaxseeds and barley significantly improved high-density lipoprotein levels in rats and reduced total cholesterol, triglycerides, and low- and very low-density lipoprotein levels. Fish oil, foxtail millet, and moong did not affect high-density lipoproteins. Our next step was to combine the nutraceuticals and test them similarly to the above, along with analyzing the lipid profiles. It was found that the barley-rich combination reduced cholesterol most effectively among the four different combinations tested. Furthermore, alkaloids, carbohydrates, proteins, steroids, and cardiac glycosides were identified by phytochemical analysis. The proximate analysis revealed the presence of 30% moisture, 6% ash, 46% carbohydrate, 10% protein, 5% fat, and 1% fiber. The study concludes that the barley-rich nutraceutical combination is beneficial in preventing hyperlipidemia.

Key words: hyperlipidemia, nutraceutical combination, phytochemicals, triton X-100, lipid profile.

Full-text options

Share this Article

Online Article Submission
• ejmanager.com

ejPort - eJManager.com
Refer & Earn
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.